VRTX Income Statement
Vertex Pharmaceuticals Inc - Revenue, Expenses & Profit Analysis
Stock Price
$496.83
Market Cap
$126.19B
P/E Ratio
32.5
EPS (TTM)
$15.30
Most Recent Quarter
Period: FY(2025-12-31)
Revenue
Total sales from operations
$12.00B
+8.9% YoY
Cost of Revenue
Direct costs of sales
$1.65B
Gross Profit
Revenue - Cost of Revenue
$10.35B
Margin: 53.7%
Operating Income
Gross Profit - Operating Expenses
$4.17B
Margin: 0.4%
Net Income
Bottom line profit
$3.95B
Margin: 0.3%
Earnings Per Share (Diluted)
Net income per share
$15.32
Profitability Metrics
Gross Margin
53.7%
Operating Margin
0.4%
Net Margin
0.3%
Return on Equity
0.2%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| FY | $12.00B | $10.35B | $4.17B | $3.95B | $15.32 |
| 2024-12-31 | $11.02B | - | - | $-535.60M | $-2.08 |
| FY | $11.02B | $9.49B | $-232.90M | $-535.60M | $-2.08 |
| 2023-12-31 | $9.87B | - | - | $3.62B | $13.89 |
| FY | $9.87B | $8.61B | $3.83B | $3.62B | $13.89 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is VRTX's revenue?
VRTX's most recent quarterly revenue was $12.00B, representing a growth of 8.9% year-over-year.
Is VRTX profitable?
VRTX reported a profit of $3.95B in the most recent quarter. The net profit margin is 0.3%.
What is VRTX's operating income?
VRTX's operating income was $4.17B in the most recent quarter. The operating margin is 0.4%.
What is VRTX's earnings per share (EPS)?
VRTX reported diluted earnings per share of $15.32 in the most recent quarter.
What is VRTX's gross profit margin?
VRTX has a gross profit margin of 53.7%, indicating the profitability of core operations before operating expenses.